According to a study published online in the journal Nature Neuroscience digoxin a drug used for treating of heart failure could be a potential medication for the treatment of amyotrophic lateral sclerosis (ALS) a progressive paralysing disease. Riluzole the sole medication approved in the US to treat the disease has only marginal benefits in patients. Scientists have now discovered that when they reduced the activity of an enzyme called sodium-potassium ATPase or limited cells' ability to make copies of this enzyme the disease's destruction of nerve cells stopped. (Read: New injectable drug to prevent heart attacks soon?) The enzyme maintains